Literature DB >> 25696571

Rationale of the SEAS study: Serial Echocardiography After Subarachnoid haemorrhage, a prospective national, multicentre, multidisciplinary, cohort study to evaluate cardiac abnormalities following intracranial haemorrhage.

I A C van der Bilt, D Hasan, G J E Rinkel, A A M Wilde, F C Visser.   

Abstract

The SEAS study is a prospective national, multicentre, multidisciplinary, cohort study in which the cardiac abnormalities following aneurysmal subarachnoid haemorrhage are studied. Incidence, clinical implications and predictive variables of cardiac abnormalities following aneurysmal subarachnoid haemorrhage will be studied. Cardiac abnormalities are defined as ECG changes, echocardiographic function abnormalities, and biochemical changes. A total of 350 patients will be included over a period of three years including follow-up.

Entities:  

Keywords:  Tako-tsubo cardiomyopathy; catecholamine; myocardial stunning; myocarditis; subarachnoid haemorrhage

Year:  2006        PMID: 25696571      PMCID: PMC2557310     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  22 in total

1.  Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage.

Authors:  P J Brouwers; E F Wijdicks; D Hasan; M Vermeulen; E F Wever; H Frericks; J van Gijn
Journal:  Stroke       Date:  1989-09       Impact factor: 7.914

2.  Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage.

Authors:  Kiran Khush; Alexander Kopelnik; Poyee Tung; Nader Banki; Michael Dae; Michael Lawton; Wade Smith; Barbara Drew; Elyse Foster; Jonathan Zaroff
Journal:  J Am Soc Echocardiogr       Date:  2005-02       Impact factor: 5.251

3.  Acute and reversible cardiomyopathy provoked by stress in women from the United States.

Authors:  Scott W Sharkey; John R Lesser; Andrey G Zenovich; Martin S Maron; Jana Lindberg; Terrence F Longe; Barry J Maron
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

Review 4.  Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction.

Authors:  Kevin A Bybee; Tomas Kara; Abhiram Prasad; Amir Lerman; Greg W Barsness; R Scott Wright; Charanjit S Rihal
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

5.  Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy.

Authors:  Jacob C Miss; Alexander Kopelnik; Landis A Fisher; Poyee P Tung; Nader M Banki; Michael T Lawton; Wade S Smith; Christopher F Dowd; Jonathan G Zaroff
Journal:  Neurosurgery       Date:  2004-12       Impact factor: 4.654

6.  Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage.

Authors:  S A Mayer; M E Fink; S Homma; D Sherman; G LiMandri; L Lennihan; R A Solomon; L M Klebanoff; A Beckford; E C Raps
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

Review 7.  Neurogenic cardiac effects of cerebrovascular disease.

Authors:  S M Oppenheimer
Journal:  Curr Opin Neurol       Date:  1994-02       Impact factor: 5.710

8.  Predictors of neurocardiogenic injury after subarachnoid hemorrhage.

Authors:  Poyee Tung; Alexander Kopelnik; Nader Banki; Ken Ong; Nerissa Ko; Michael T Lawton; Daryl Gress; Barbara Drew; Elyse Foster; William Parmley; Jonathan Zaroff
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

9.  Cardiac Effects of Stroke.

Authors:  Raymond T.F. Cheung; Vladimir Hachinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

10.  Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage.

Authors:  G Di Pasquale; G Pinelli; A Andreoli; G Manini; P Grazi; F Tognetti
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

View more
  1 in total

1.  Cardiac events within one year after a subarachnoid haemorrhage: The predictive value of troponin elevation after aneurysm occlusion.

Authors:  Annemarie Akkermans; Linda M Peelen; Judith A van Waes; Gabriël J Rinkel; Wilton A van Klei
Journal:  Eur J Prev Cardiol       Date:  2018-05-17       Impact factor: 7.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.